Skip to content
Menu

Lantern Pharma Inc. LTRN

Full chart Compare
Set alert

Price alert · LTRN

All alert types
0.25 USD -0.04 (-13.73%)

Regular-session close

0.25 0.00 +0.20%

After hours · Nov 20, 4:26 PM ET

0.2286 Day range 0.2831
0.245 52-week range 4.17
YTD
-91.91%
1 year
-91.83%

Held by funds

6 US ETFs and mutual funds hold LTRN · largest positions

  1. VTI 0.00% of fund $176.21K
  2. IJE 0.01% of fund $72.67K
  3. VXF 0.00% of fund $54.12K
  4. MEDX 0.04% of fund $6.46K
  5. DFSU 0.00% of fund $634
  6. DFAC 0.00% of fund $212

Ownership

  • Institutions 24.1%
  • Insiders 14.7%
  • Public and other holders 61.2%
Held by insiders 14.74%
Held by institutions 24.10%
Float held by institutions 28.27%
Institutions 49

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
Vanguard Group Inc3.37%363,7201.10MSep 29, 2024
CM Management, LLC1.72%185,000558.70KSep 29, 2024
NewEdge Advisors, LLC1.27%137,338414.76KSep 29, 2024
Geode Capital Management, LLC0.81%87,435264.05KSep 29, 2024
Renaissance Technologies, LLC0.78%84,000253.68KSep 29, 2024
Davenport & Co LLC0.50%53,814162.52KSep 29, 2024

Top mutual fund holders

Top mutual fund holders
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund2.37%256,113773.46KSep 29, 2024
Vanguard Extended Market Index Fund0.92%99,265299.78KSep 29, 2024
Fidelity Extended Market Index Fund0.43%46,104139.23KOct 30, 2024
Listed Funds Tr-Horizon Kinetics Medical ETF0.26%27,58283.30KSep 29, 2024
iShares Micro Cap ETF0.16%16,78250.68KOct 30, 2024
Fidelity Total Market Index Fund0.14%15,44046.63KOct 30, 2024

Included in Plus and up

Sign in to see Institutional ownership

How much funds own from their 13F filings, quarter by quarter, and the largest holders.

Free with an account

Sign in to see Insider activity

Two years of insider buying and selling by month, marked on the price.

Included in Plus and up

Sign in to see Congress trading

Every stock trade disclosed by members of the US Senate and House.

Leadership team

Who runs LTRN, and what each was last paid

Panna Sharma, President, Chief Executive Officer & DirectorAverage age 64

LTRN key executives
NameTitlePayAge
Panna SharmaPresident, Chief Executive Officer & Director$764K 55
David R. MargraveChief Financial Officer & Secretary$541K 65
Kishor Gopaldas BhatiaChief Scientific Officer & Scientific Consultant$222K 71
Marc C. ChamberlainChief Medical Officer of Starlight Therapeutics— —
Peter L. NaraCo-Founder & Advisor— —

Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.

Free with an account

Sign in to see CEO compensation

What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.

Free with an account

Sign in to see Board of directors

Who sits on the board, who chairs it, and how long each director has served.

LTRN insiders
InsiderRelationLatest transactionDateShares held
FLETCHER AARON G.L.Beneficial Owner of more than 10% of a Class of SecurityConversion of Exercise of derivative securityJan 16, 20240
KEYSER DONALD JEFFREY PH.DDirectorConversion of Exercise of derivative securityJul 23, 20240
KREIS LESLIE W JRBeneficial Owner of more than 10% of a Class of SecuritySaleMay 23, 20240